rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
16
|
pubmed:dateCreated |
2002-7-25
|
pubmed:abstractText |
A library of compounds biased toward opioid receptor antagonist activity was prepared by incorporating N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)morphans as the core scaffold using simultaneous solution phase synthetic methodology. From this library, N-phenylpropyl-4beta-methyl-5-(3-hydroxyphenyl)-7alpha-[3-(1-piperidinyl)propanamido]morphan [(-)-3b] was identified as the first potent and selective kappa opioid receptor antagonist from the 5-phenylmorphan class of opioids.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-2623
|
pubmed:author |
pubmed-author:AtkinsonRobert NRN,
pubmed-author:BurgessJason PJP,
pubmed-author:CantrellBuddy EBE,
pubmed-author:CarrollF IvyFI,
pubmed-author:DerschChristina MCM,
pubmed-author:FixScott ESE,
pubmed-author:GigstadKenneth MKM,
pubmed-author:MascarellaS WayneSW,
pubmed-author:NamdevNiveditaN,
pubmed-author:RothmanRichard BRB,
pubmed-author:ThomasJames BJB,
pubmed-author:VinsonN ArianeNA,
pubmed-author:XuHengH,
pubmed-author:ZimmermanDennis MDM
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3524-30
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12139463-Animals,
pubmed-meshheading:12139463-Bicyclo Compounds, Heterocyclic,
pubmed-meshheading:12139463-Brain,
pubmed-meshheading:12139463-CHO Cells,
pubmed-meshheading:12139463-Combinatorial Chemistry Techniques,
pubmed-meshheading:12139463-Cricetinae,
pubmed-meshheading:12139463-Guinea Pigs,
pubmed-meshheading:12139463-Humans,
pubmed-meshheading:12139463-Ligands,
pubmed-meshheading:12139463-Morphinans,
pubmed-meshheading:12139463-Radioligand Assay,
pubmed-meshheading:12139463-Rats,
pubmed-meshheading:12139463-Receptors, Opioid, kappa,
pubmed-meshheading:12139463-Stereoisomerism,
pubmed-meshheading:12139463-Structure-Activity Relationship
|
pubmed:year |
2002
|
pubmed:articleTitle |
Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphans.
|
pubmed:affiliation |
Chemistry and Life Sciences, Research Triangle Institute, Research Triangle Park, NC 27709, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, U.S. Gov't, P.H.S.
|